Molecular Partners Ag (MOLN) Market Capitalization (2021 - 2026)

Molecular Partners Ag (MOLN) has reported Market Capitalization for 6 consecutive years, with $156.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Market Capitalization rose 1.34% year-over-year to $156.2 million in Q2 2026; TTM through Jun 2026 was $156.2 million, a 1.34% increase from a year earlier, with the FY2025 full-year figure at $176.0 million, down 8.17% from the prior year.
• Market Capitalization was $156.2 million for Q2 2026 at Molecular Partners Ag, down from $160.2 million in the prior quarter.
• Over five years, Market Capitalization peaked at $663.6 million in Q1 2022 and troughed at $149.2 million in Q3 2023.
• A 5-year average of $212.4 million and a median of $180.5 million in 2024 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization plunged 67.2% in 2023 and climbed 26.11% in 2024, its largest moves.
• Over 5 years, Market Capitalization stood at $236.1 million in 2022, then slumped by 35.64% to $152.0 million in 2023, then rose by 26.11% to $191.6 million in 2024, then retreated by 8.17% to $176.0 million in 2025, then declined by 11.22% to $156.2 million in 2026.
• The last three Market Capitalization figures came in at $156.2 million (Q2 2026), $160.2 million (Q1 2026), and $176.0 million (Q4 2025), per Business Quant data.